NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia flag Australia · Delayed Price · Currency is AUD
0.1400
+0.0050 (3.70%)
Jan 30, 2026, 4:10 PM AEST

ASX:NSB Statistics

Total Valuation

ASX:NSB has a market cap or net worth of AUD 44.90 million. The enterprise value is 37.63 million.

Market Cap44.90M
Enterprise Value 37.63M

Important Dates

The next estimated earnings date is Wednesday, February 25, 2026.

Earnings Date Feb 25, 2026
Ex-Dividend Date n/a

Share Statistics

ASX:NSB has 332.58 million shares outstanding. The number of shares has increased by 1.49% in one year.

Current Share Class 332.58M
Shares Outstanding 332.58M
Shares Change (YoY) +1.49%
Shares Change (QoQ) -0.49%
Owned by Insiders (%) 9.29%
Owned by Institutions (%) 3.17%
Float 241.65M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 2.67
P/TBV Ratio 6.20
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -20.39
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 49.56

Current Ratio 49.56
Quick Ratio 49.35
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -815.72

Financial Efficiency

Return on equity (ROE) is -16.65% and return on invested capital (ROIC) is -11.33%.

Return on Equity (ROE) -16.65%
Return on Assets (ROA) -11.21%
Return on Invested Capital (ROIC) -11.33%
Return on Capital Employed (ROCE) -11.95%
Weighted Average Cost of Capital (WACC) 10.56%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +255.26% in the last 52 weeks. The beta is 1.15, so ASX:NSB's price volatility has been higher than the market average.

Beta (5Y) 1.15
52-Week Price Change +255.26%
50-Day Moving Average 0.12
200-Day Moving Average 0.13
Relative Strength Index (RSI) 50.86
Average Volume (20 Days) 797,041

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit 473
Operating Income -2.01M
Pretax Income -1.85M
Net Income -1.85M
EBITDA -1.92M
EBIT -2.01M
Earnings Per Share (EPS) -0.01
Full Income Statement

Balance Sheet

The company has 7.27 million in cash and n/a in debt, with a net cash position of 7.27 million or 0.02 per share.

Cash & Cash Equivalents 7.27M
Total Debt n/a
Net Cash 7.27M
Net Cash Per Share 0.02
Equity (Book Value) 16.81M
Book Value Per Share 0.05
Working Capital 7.25M
Full Balance Sheet

Cash Flow

Operating Cash Flow -941,329
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ASX:NSB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1.49%
Shareholder Yield -1.49%
Earnings Yield -4.11%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1